If you need more lookups,
subscriptions start at $34 USD/month.
Len Pattenden Location
London, GB
Len Pattenden Work
Head of CMC @ (April 2024 - Present)
Vector Upstream Development Group Leader II @ (May 2018 - November 2018)
Director @ CMC Biopharma (May 2021 - Present)
Head of Biotherapeutic Development and Drug Supply @ (November 2018 - Present)
Vector Upstream Development Group Leader Ii @ (June 2018 - November 2018)
Senior Group Research and Development @ (December 2017 - June 2018)
Technical Capability Leader @ (March 2016 - December 2017)
Senior Scientist - Fermentation and Cell Culture Development @ (April 2012 - March 2016)
Senior Scientist - Biotechnology and Microbiology @ Ethanol Technologies (August 2011 - April 2012)
Senior Postdoctoral Fellow @ (February 2009 - August 2011)
Senior Postdoctoral Fellow @ (June 2005 - February 2009)
Centre Manager - Aibn @ (January 2004 - June 2005)
Research Scientist @ (January 1998 - January 2003)
PHD Student and Demonstrator - Tutor @ (January 1997 - January 2003)
Len Pattenden Education
Queensland University of Technology 1997-2004
Len Pattenden Skills
Cell Culture
Protein Chemistry
Fermentation
Molecular Biology
Chromatography
Lifesciences
Biochemistry
Protein Purification
Analytical Chemistry
Circular Dichroism
Synthetic Biology
Biophysics
Physical Biochemistry
X-ray crystallography
Molecular Modeling
Surface Plasmon Resonance
bioassay
Purification
Biotechnology
Science
Drug Discovery
Cell Biology
HPLC
Pharmaceutical Industry
Life Sciences
Len Pattenden Summary
Len Pattenden, based in London, GB, is currently a Head of CMC at Fondazione Telethon. Len Pattenden brings experience from previous roles at Adaptimmune, CMC Biopharma, Cancer Research Uk and Adaptimmune Us. Len Pattenden holds a 1997 - 2004 Queensland University of Technology. With a robust skill set that includes Cell Culture, Protein Chemistry, Fermentation, Molecular Biology, Chromatography and more. Len Pattenden has 2 emails on RocketReach.
Looking for a different Len Pattenden?
Find contact details for 700 million professionals.